Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-050620
Filing Date
2024-12-10
Accepted
2024-12-10 16:26:55
Documents
1
Period of Report
2024-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1733866009.html 4  
1 FORM 4 wk-form4_1733866009.xml 4 4660
  Complete submission text file 0001628280-24-050620.txt   6135
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3515 LYMAN BLVD. CHASKA MN 55318
Business Address
Josephs Paul (Reporting) CIK: 0002022547 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27446 | Film No.: 241538836